(Q46490866)

22 December 2017

title

Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk (English)

1 reference

22 December 2017

1 reference

2

1 reference

22 December 2017

Rod Jackson

3

1 reference

22 December 2017

Simon J. Griffin

6

1 reference

22 December 2017

Parinya Chamnan

object named as

P Chamnan

1

0 references

Nicholas J. Wareham

5

object named as

N J Wareham

1 reference

22 December 2017

4

K T Khaw

1 reference

22 December 2017

publication date

23 September 2010

1 reference

22 December 2017

published in

Diabetologia

1 reference

22 December 2017

volume

54

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

291-299

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-010-1914-6

exact match

0 references

cites work

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Risk factor thresholds: their existence under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Effect of nateglinide on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Cardiovascular disease risk profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1914-6

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

21 January 2018

1 reference

12 December 2020

EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer

1 reference

12 December 2020

The national glycohemoglobin standardization program: a five-year progress report.

1 reference

12 December 2020

Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group

1 reference

12 December 2020

Cardiovascular risk prediction: are we there yet?

1 reference

12 December 2020

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

1 reference

12 December 2020

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

1 reference

12 December 2020

10.1007/S00125-010-1914-6

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017